Individuals with intellectual disability frequently use antipsychotics for many years. This may have detrimental health effects, including neurological symptoms and metabolic and hormonal dysregulation, the latter possibly affecting bone metabolism. There is large variability in the degree in which antipsychotic agents lead to these health problems. In the current study we investigated potential determinants of physical symptoms and biological parameters known to be associated with use of antipsychotics in a convenience sample of 99 individuals with intellectual disability who had used antipsychotics for more than one year for behavioural symptoms. We focused on extrapyramidal symptoms; on overweight and presence of components of the metabolic syndrome; and on elevated plasma prolactin and bone turnover parameters. As predictor variables, we used patient (sex, age, genetic polymorphisms, and severity of intellectual disability) and medication use (type and dosage) characteristics. We found extrapyramidal symptoms to be present in 53%, overweight or obesity in 46%, and the metabolic syndrome in 11% of participants. Hyperprolactineaemia and one or more elevated bone turnover markers were present in 17% and 25%, respectively. Higher age and more severe intellectual disability were associated with dyskinesia and a higher dosage of the antipsychotic drug was associated with parkinsonism. Less severe intellectual disability was related to higher Body Mass Index. Use of atypical antipsychotics was associated with higher diastolic blood pressure and elevated fasting glucose. Clinicians who prescribe antipsychotics in individuals with intellectual disability should carefully balance the potential benefits of prolonged treatment against the risk of health hazards associated with the use of antipsychotics.

adolescent, adult, age, aged, akathisia, article, behavior disorder, blood pressure, body mass, convenience sample, diastolic blood pressure, disease severity, dopamine D2 receptor gene, dopamine D3 receptor gene, extrapyramidal symptom, female, genetic polymorphism, glucose blood level, human, hyperprolactinemia, intellectual impairment, long term care, major clinical study, male, metabolic syndrome X, obesity, off label drug use, parkinsonism, prolactin blood level, side effect, tardive dyskinesia, triacylglycerol blood level, waist circumference
dx.doi.org/10.1016/j.ridd.2013.05.016, hdl.handle.net/1765/41087
Research in Developmental Disabilities
Erasmus MC: University Medical Center Rotterdam

Kuijper, G, Mulder, H, Evenhuis, H.M, Scholte, F.A, Visser, F, & Hoekstra, P.J. (2013). Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics. Research in Developmental Disabilities, 34(9), 2799–2809. doi:10.1016/j.ridd.2013.05.016